Milestone Pharmaceuticals Inc. (MIST) Operating cash flow 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.0MFY2025 · since FY2018: -$21.0M → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | -70.0% |
| FY2024 | -$28.8M | +37.9% |
| FY2023 | -$46.4M | +11.5% |
| FY2022 | -$52.5M | -57.9% |
| FY2021 | -$33.2M | +34.5% |
| FY2020 | -$50.7M | +0.8% |
| FY2019 | -$51.2M | -143.0% |
| FY2018 | -$21.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIST financial trends
MIST RevenueMIST Net incomeMIST Net marginMIST Gross profitMIST Gross marginMIST Operating incomeMIST Operating marginMIST Free cash flowMIST Capital expendituresMIST Return on equityMIST Stock buybacksMIST Dividends paidMIST Total assetsMIST Total liabilitiesMIST Shareholders’ equityMIST overview →